Doctors Without Borders: Tuberculosis Drug Remains Too Expensive, Despite New Price
October 09, 2019
October 09, 2019
GENEVA, Switzerland, Oct. 9 -- The Doctors Without Borders/Medecins Sans Frontieres issued the following news:
GENEVA/NEW YORK -- The new price offered to South Africa for the the anti-tuberculosis (TB) drug delamanid remains too high and should be lowered and offered to all countries, said the international medical humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) today.
Delamanid is one of the most expensive drugs used to treat drug-resi . . .
GENEVA/NEW YORK -- The new price offered to South Africa for the the anti-tuberculosis (TB) drug delamanid remains too high and should be lowered and offered to all countries, said the international medical humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) today.
Delamanid is one of the most expensive drugs used to treat drug-resi . . .